Director, Department of Neurosurgery Geisigner Health System
Neurosurgery
Dr. Steven A. Toms, MD
|
|
Give Review
Steven Toms practices Neurosurgery. He studied medicine at Warren Alpert Medical School of Brown University. He over the years received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Fellow (FAANS)" and "Fellow (FACS)". Doctor Steven A. Toms, MD is a published MD. He has 54 papers published. The most current publication "Gamma-ray mutagen sensitivity and survival in patients with glioma." Steven Toms accepts all Medicare patients.
Publications
- Clinical Use of Tumor Treating Fields: Discussion.
- Comparative effectiveness research in neurotrauma.
- Stereotactic radiosurgical treatment of Brain metastases to the choroid plexus.
- The molecular pathobiology of metastasis to the Brain: a review.
- Nanoimaging and neurological surgery.
- Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme.
- Stereotactic radiosurgery as single-modality treatment of incidentally identified renal cell carcinoma Brain metastases.
- Stereotactic radiosurgical treatment of Brain metastases in older patients.
- Stereotactic radiosurgical treatment of parenchymal Brain metastases from prostate adenocarcinoma.
- Genomic expression patterns distinguish long-term from short-term glioblastoma survivors: a preliminary feasibility study.
- Clinical problem-solving: island intruder.
- Neurogenesis in the postnatal human epileptic Brain.
- Choroid plexus metastasis.
- Intraoperative optical spectroscopy identifies infiltrating glioma margins with high sensitivity.
- Quantum dots are phagocytized by macrophages and colocalize with experimental Gliomas.
- Macrophage-mediated colocalization of quantum dots in experimental glioma.
- Symptomatic pituitary metastases from renal cell carcinoma.
- Five-year survivors of Brain metastases: a single-institution report of 32 patients.
- RPA classification has prognostic significance for surgically resected single Brain metastasis.
- Neuro-oncological applications of optical spectroscopy.
- Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme.
- Proteomic-based prognosis of Brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry.
- In vivo optical spectroscopy detects radiation damage in Brain tissue.
- Protein profiling in Brain tumors using mass spectrometry: feasibility of a new technique for the analysis of protein expression.
- Allelic losses in oligodendroglial and oligodendroglioma-like neoplasms: analysis using microsatellite repeats and polymerase chain reaction.
- Evidence for phosphatidylinositol 3-kinase-Akt-p7S6K pathway activation and transduction of mitogenic signals by platelet-derived growth factor in meningioma cells.
- Molecular biology of Brain metastasis.
- The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTF™-100A System.
- High fluorodeoxyglucose ((18)F)PET-uptake lymph nodes in a patient with Chordoma: Tumor metastasis or sarcoidosis?
- Gamma knife stereotactic radiosurgery for the management of incidentally-identified Brain metastasis from non-small cell lung cancer.
- Mitogenic signal transduction pathways in Meningiomas: novel targets for meningioma chemotherapy?
- The utility of external beam radiation and intracystic 32P radiation in the treatment of Craniopharyngiomas.
- Detection of proliferating S-phase Brain tumor cells by in situ DNA replication.
- In vivo Brain tumor demarcation using optical spectroscopy.
- Fiducial point placement and the accuracy of point-based, rigid body registration.
- December 2000: 6 month old boy with 2 week history of progressive lethargy.
- Brain tumor demarcation using optical spectroscopy; an in vitro study.
- Basic surgical techniques in the resection of malignant Gliomas.
- Gamma-ray mutagen sensitivity and survival in patients with glioma.
- Antagonist effect of insulin-like growth factor I on protein kinase inhibitor-mediated apoptosis in human glioblastoma cells in association with bcl-2 and bcl-xL.
- Thyroid hormone depletion inhibits Astrocytoma proliferation via a p53-independent induction of p21 (WAF1/CIP1).
- The transforming activities of MDM2 in cultured neonatal rat astrocytes.
- Evaluation of a program to prevent head and Spinal cord injuries: a comparison between middle school and high school.
- Outcome predictors in the early withdrawal of life support: issues of justice and allocation for the severely Brain injured.
- Inhibitory effects of tamoxifen and tumor necrosis factor alpha on human glioblastoma cells.
- Pathobiology of Brain metastases.
- July 2002: 66-year-old female with a one-year history of progressive left proptosis.
- In vivo optical imaging using quantum dots for the management of Brain tumors.
- New prospects for management and treatment of inoperable and recurrent skull base Meningiomas.
- Metastases to the Brain: current management perspectives.
- Lovastatin is a potent inhibitor of meningioma cell proliferation: evidence for inhibition of a mitogen associated protein kinase.
- Nanotechnology in proteomics.
- Imaging characteristics of zinc sulfide shell, cadmium telluride core quantum dots.
Schools
Brown University Alpert Medical School
Cleveland Clinic Foundation
Mdanderson
Procedures Preformed
- CerebroSpinal Fluid (CSF) Shunt - Insertion, Repair or Removal
- Craniectomy, Craniotomy, Surgery of Skull Base, Neuroendoscopy
- Deep Brain Stimulation
- Dural Repair or Other Spinal Spinal Cord Repair
- View All
Conditions Treated
- Acoustic Neuroma
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Aneurysm
- Brain Cancer
- View All
Doctors Specialties
- Neurosurgery
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FAANS)
- Fellow (FACS)
Education
-
Cleveland Clinic Foundation -
Warren Alpert Medical School of Brown University
Drug Facts
| NPI NUMBER | 1780632679 | |
| NPPES Provider LastName | TOMS | |
| NPPES Provider FirstName | STEVEN | |
| NPPES Provider ZIPCode | 178229800 | |
| NPPES Provider State | PA | |
| Specialty Description | Neurosurgery | |
| Total Claim Count | 54.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1780632679 |
| Last Name Of The Provider | TOMS |
| First Name Of The Provider | STEVEN |
| View All |
Similar Doctors
|
|
Dr. Hani J. Tuffaha, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Clemens M. Schirmer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fred G. McMurry, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jonathan R. Slotkin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Darren L. Jacobs, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amir Kershenovich Rabinovitz, MD |
|
|
Dr. Sheela Vivekanandan, MD |
|
|
Jesna S. Mathew, MB BS |